Determination of B-cell epitopes in patients with celiac disease: Peptide microarrays

Rok Seon Choung, Eric V. Marietta, Carol T. Van Dyke, Tricia L. Brantner, John Rajasekaran, Pankaj J. Pasricha, Tianhao Wang, Kang Bei, Karthik Krishna, Hari K. Krishnamurthy, Melissa R. Snyder, Vasanth Jayaraman, Joseph A Murray

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background Most antibodies recognize conformational or discontinuous epitopes that have a specific 3- dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve laborious, high-cost peptide screening programs. Here, we present a novel microarray method for identifying discontinuous B-cell epitopes in celiac disease (CD) by using a silicon-based peptide array and computational methods. Methods Using a novel silicon-based microarray platform with a multi-pillar chip, overlapping 12-mer peptide sequences of all native and deamidated gliadins, which are known to trigger CD, were synthesized in situ and used to identify peptide epitopes. Results Using a computational algorithm that considered disease specificity of peptide sequences, 2 distinct epitope sets were identified. Further, by combining the most discriminative 3-mer gliadin sequences with randomly interpolated3- or 6-mer peptide sequences, novel discontinuous epitopes were identified and further optimized to maximize disease discrimination. The final discontinuous epitope sets were tested in a confirmatory cohort of CD patients and controls, yielding 99% sensitivity and 100% specificity. Conclusions These novel sets of epitopes derived from gliadin have a high degree of accuracy in differentiating CD from controls, compared with standard serologic tests. The method of ultrahigh- density peptide microarray described here would be broadly useful to develop highfidelity diagnostic tests and explore pathogenesis.

Original languageEnglish (US)
Article numbere0147777
JournalPLoS One
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

B-Lymphocyte Epitopes
celiac disease
Celiac Disease
Microarrays
epitopes
B-lymphocytes
Epitopes
peptides
Peptides
Gliadin
gliadin
Silicon
silicon
methodology
Serologic Tests
Computational methods
Routine Diagnostic Tests
immunologic techniques
diagnostic techniques
Screening

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Choung, R. S., Marietta, E. V., Van Dyke, C. T., Brantner, T. L., Rajasekaran, J., Pasricha, P. J., ... Murray, J. A. (2016). Determination of B-cell epitopes in patients with celiac disease: Peptide microarrays. PLoS One, 11(1), [e0147777]. https://doi.org/10.1371/journal.pone.0147777

Determination of B-cell epitopes in patients with celiac disease : Peptide microarrays. / Choung, Rok Seon; Marietta, Eric V.; Van Dyke, Carol T.; Brantner, Tricia L.; Rajasekaran, John; Pasricha, Pankaj J.; Wang, Tianhao; Bei, Kang; Krishna, Karthik; Krishnamurthy, Hari K.; Snyder, Melissa R.; Jayaraman, Vasanth; Murray, Joseph A.

In: PLoS One, Vol. 11, No. 1, e0147777, 01.01.2016.

Research output: Contribution to journalArticle

Choung, RS, Marietta, EV, Van Dyke, CT, Brantner, TL, Rajasekaran, J, Pasricha, PJ, Wang, T, Bei, K, Krishna, K, Krishnamurthy, HK, Snyder, MR, Jayaraman, V & Murray, JA 2016, 'Determination of B-cell epitopes in patients with celiac disease: Peptide microarrays', PLoS One, vol. 11, no. 1, e0147777. https://doi.org/10.1371/journal.pone.0147777
Choung RS, Marietta EV, Van Dyke CT, Brantner TL, Rajasekaran J, Pasricha PJ et al. Determination of B-cell epitopes in patients with celiac disease: Peptide microarrays. PLoS One. 2016 Jan 1;11(1). e0147777. https://doi.org/10.1371/journal.pone.0147777
Choung, Rok Seon ; Marietta, Eric V. ; Van Dyke, Carol T. ; Brantner, Tricia L. ; Rajasekaran, John ; Pasricha, Pankaj J. ; Wang, Tianhao ; Bei, Kang ; Krishna, Karthik ; Krishnamurthy, Hari K. ; Snyder, Melissa R. ; Jayaraman, Vasanth ; Murray, Joseph A. / Determination of B-cell epitopes in patients with celiac disease : Peptide microarrays. In: PLoS One. 2016 ; Vol. 11, No. 1.
@article{bbcc2693cd424b7eae7fe11f261b6e1a,
title = "Determination of B-cell epitopes in patients with celiac disease: Peptide microarrays",
abstract = "Background Most antibodies recognize conformational or discontinuous epitopes that have a specific 3- dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve laborious, high-cost peptide screening programs. Here, we present a novel microarray method for identifying discontinuous B-cell epitopes in celiac disease (CD) by using a silicon-based peptide array and computational methods. Methods Using a novel silicon-based microarray platform with a multi-pillar chip, overlapping 12-mer peptide sequences of all native and deamidated gliadins, which are known to trigger CD, were synthesized in situ and used to identify peptide epitopes. Results Using a computational algorithm that considered disease specificity of peptide sequences, 2 distinct epitope sets were identified. Further, by combining the most discriminative 3-mer gliadin sequences with randomly interpolated3- or 6-mer peptide sequences, novel discontinuous epitopes were identified and further optimized to maximize disease discrimination. The final discontinuous epitope sets were tested in a confirmatory cohort of CD patients and controls, yielding 99{\%} sensitivity and 100{\%} specificity. Conclusions These novel sets of epitopes derived from gliadin have a high degree of accuracy in differentiating CD from controls, compared with standard serologic tests. The method of ultrahigh- density peptide microarray described here would be broadly useful to develop highfidelity diagnostic tests and explore pathogenesis.",
author = "Choung, {Rok Seon} and Marietta, {Eric V.} and {Van Dyke}, {Carol T.} and Brantner, {Tricia L.} and John Rajasekaran and Pasricha, {Pankaj J.} and Tianhao Wang and Kang Bei and Karthik Krishna and Krishnamurthy, {Hari K.} and Snyder, {Melissa R.} and Vasanth Jayaraman and Murray, {Joseph A}",
year = "2016",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0147777",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Determination of B-cell epitopes in patients with celiac disease

T2 - Peptide microarrays

AU - Choung, Rok Seon

AU - Marietta, Eric V.

AU - Van Dyke, Carol T.

AU - Brantner, Tricia L.

AU - Rajasekaran, John

AU - Pasricha, Pankaj J.

AU - Wang, Tianhao

AU - Bei, Kang

AU - Krishna, Karthik

AU - Krishnamurthy, Hari K.

AU - Snyder, Melissa R.

AU - Jayaraman, Vasanth

AU - Murray, Joseph A

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background Most antibodies recognize conformational or discontinuous epitopes that have a specific 3- dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve laborious, high-cost peptide screening programs. Here, we present a novel microarray method for identifying discontinuous B-cell epitopes in celiac disease (CD) by using a silicon-based peptide array and computational methods. Methods Using a novel silicon-based microarray platform with a multi-pillar chip, overlapping 12-mer peptide sequences of all native and deamidated gliadins, which are known to trigger CD, were synthesized in situ and used to identify peptide epitopes. Results Using a computational algorithm that considered disease specificity of peptide sequences, 2 distinct epitope sets were identified. Further, by combining the most discriminative 3-mer gliadin sequences with randomly interpolated3- or 6-mer peptide sequences, novel discontinuous epitopes were identified and further optimized to maximize disease discrimination. The final discontinuous epitope sets were tested in a confirmatory cohort of CD patients and controls, yielding 99% sensitivity and 100% specificity. Conclusions These novel sets of epitopes derived from gliadin have a high degree of accuracy in differentiating CD from controls, compared with standard serologic tests. The method of ultrahigh- density peptide microarray described here would be broadly useful to develop highfidelity diagnostic tests and explore pathogenesis.

AB - Background Most antibodies recognize conformational or discontinuous epitopes that have a specific 3- dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve laborious, high-cost peptide screening programs. Here, we present a novel microarray method for identifying discontinuous B-cell epitopes in celiac disease (CD) by using a silicon-based peptide array and computational methods. Methods Using a novel silicon-based microarray platform with a multi-pillar chip, overlapping 12-mer peptide sequences of all native and deamidated gliadins, which are known to trigger CD, were synthesized in situ and used to identify peptide epitopes. Results Using a computational algorithm that considered disease specificity of peptide sequences, 2 distinct epitope sets were identified. Further, by combining the most discriminative 3-mer gliadin sequences with randomly interpolated3- or 6-mer peptide sequences, novel discontinuous epitopes were identified and further optimized to maximize disease discrimination. The final discontinuous epitope sets were tested in a confirmatory cohort of CD patients and controls, yielding 99% sensitivity and 100% specificity. Conclusions These novel sets of epitopes derived from gliadin have a high degree of accuracy in differentiating CD from controls, compared with standard serologic tests. The method of ultrahigh- density peptide microarray described here would be broadly useful to develop highfidelity diagnostic tests and explore pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84959036603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959036603&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0147777

DO - 10.1371/journal.pone.0147777

M3 - Article

C2 - 26824466

AN - SCOPUS:84959036603

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e0147777

ER -